UBS upgraded Arkema to Buy from Neutral with a price target of EUR 120, up from EUR 95. The analyst cites the company’s EBITDA recovery and 50% free cash flow conversion for the upgrade.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on ARKAY: